닫기
18.97.9.173
18.97.9.173
close menu
Accredited
비알코올성 지방간이 다른 내과질환에 미치는 임상적 영향
Clinical impact of non-alcoholic fatty Liver disease on other medical diseases
윤중원 ( Jung Won Yun ) , 조용균 ( Yong Kyun Cho )
UCI I410-ECN-0102-2012-410-000347581

Non alcoholic fatty liver disease (NAFLD) has been recognized as a hepatic manifestation of systemic metabolic disease associated with insulin resistance. Recent studies have reported that NAFLD is related with various systemic complications such as cardiovascular, renal, metabolic disease independent of obesity, other component of metabolic syndrome (MetS). Thus, NAFLD should be newly regarded as an early mediator of systemic metabolic disease as well as liver specific disease. The mechanisms of adverse effect of NAFLD on other medical diseases are not fully understood, so further study is needed for understanding and future management strategies of NAFLD. (Korean J Med 76:25-29, 2009)

[자료제공 : 네이버학술정보]
×